NCT00245037
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +81 more
- Locations
-
- Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States
Clinical trial condition
Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.
NCT00245037
NCT01725204
NCT00448357
NCT00691015
NCT00448201
NCT00376922
NCT00513474
NCT00112593
NCT00795769